<DOC>
	<DOCNO>NCT00161434</DOCNO>
	<brief_summary>The primary objective research study assess daily valacyclovir therapy suppression HSV-2 reactivation associate decrease mucosal HIV shed individual co-infected HSV-2 HIV .</brief_summary>
	<brief_title>A Study Valacyclovir Suppress HSV HIV Shedding Coinfected Persons</brief_title>
	<detailed_description>Sexually transmit disease genital ulcer disease ( GUD ) contribute significantly spread HIV , presence associate high rate HIV acquisition susceptible individual . Herpes simplex virus-2 ( HSV-2 ) major cause GUD develop develop country . The primary objective research study assess daily valacyclovir therapy suppression HSV-2 reactivation associate decrease mucosal HIV shed individual co-infected HSV-2 HIV . This study randomize , double-blind , placebo-controlled , crossover trial . Sixty men sex men ( MSM ) randomize first receive either valacyclovir , 1 gram day , match placebo 8 week . After 2-week washout period participant receive placebo , subject switch treatment next 8 week . At screening , informed consent obtain individual blood draw test antibody status HIV HSV well monitor CD4 count plasma HIV RNA determination . At enrollment , oral , genital , rectal specimen obtain additional blood drawn . Participants give two-week supply study medication instruct technique collect daily home sample complete diary . Following enrollment , ask collect daily home oral genital sample , well semen sample twice week , full 18 week study . Participants return clinic three time per week follow-up , collection oral rectal specimen , additional study medication . Rectal Biopsy perform week 8 18 individual sign additional rectal biopsy consent form .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>HIV seropositive HSV2 seropositive MSM ( men sex men ) 18 year old old Known history adverse reaction acyclovir valacyclovir Planned open label use acyclovir , valacyclovir famciclovir</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>HIV-1</keyword>
</DOC>